Elbit Med Tech Cash Flow Conversion Efficiency
Elbit Med Tech cash flow conversion efficiency. Based on the latest financial reports, Elbit Med Tech (EMTC) has a cash flow conversion efficiency ratio of -0.003x as of June 2021. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-116.00K ≈ $-310.99 USD) by net assets (ILA39.07 Million ≈ $104.75K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Elbit Med Tech (2008–2022)
Cash flow conversion efficiency of Elbit Med Tech from 2008 to 2022. This chart illustrates how Elbit Med Tech's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Elbit Med Tech stock price for real-time trading data and today's change.
Elbit Med Tech Cash Flow Conversion Ratio Explained
Elbit Med Tech cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Elbit Med Tech Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Elbit Med Tech ranked by their cash flow conversion efficiency. Also see EMTC market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SaverOne 2014 Ltd. American Depositary Shares
NASDAQ:SVRE
|
-0.340x |
|
Enova Mining Ltd
AU:ENV
|
-0.031x |
|
Heads UP Ventures Limited
NSE:HEADSUP
|
-0.078x |
|
Vanquis Banking Group PLC
LSE:VANQ
|
0.406x |
|
Smartfren Telecom Tbk
JK:FREN
|
-0.016x |
|
Luminar Technologies Inc. Class A
NASDAQ:LAZRQ
|
0.106x |
|
Gaucho Group Holdings Inc
NASDAQ:VINO
|
-0.853x |
|
Clasquin
PA:ALCLA
|
-0.099x |
Annual Cash Flow Conversion Efficiency for Elbit Med Tech (2008–2022)
The table below shows the annual cash flow conversion efficiency of Elbit Med Tech from 2008 to 2022. Review Elbit Med Tech free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | ILA25.01 Million ≈ $67.05K |
ILA-526.00K ≈ $-1.41K |
-0.021x | -17.39% |
| 2021-12-31 | ILA30.53 Million ≈ $81.86K |
ILA-547.00K ≈ $-1.47K |
-0.018x | -22.43% |
| 2020-12-31 | ILA46.06 Million ≈ $123.48K |
ILA-674.00K ≈ $-1.81K |
-0.015x | -194.02% |
| 2019-12-31 | ILA-36.69 Million ≈ $-98.36K |
ILA-571.00K ≈ $-1.53K |
0.016x | -51.67% |
| 2018-12-31 | ILA-15.49 Million ≈ $-41.54K |
ILA-499.00K ≈ $-1.34K |
0.032x | +353.51% |
| 2017-12-31 | ILA-42.38 Million ≈ $-113.63K |
ILA-301.00K ≈ $-806.97 |
0.007x | -23.32% |
| 2016-12-31 | ILA-31.64 Million ≈ $-84.81K |
ILA-293.00K ≈ $-785.52 |
0.009x | -52.52% |
| 2015-12-31 | ILA-13.38 Million ≈ $-35.87K |
ILA-261.00K ≈ $-699.73 |
0.020x | +104.38% |
| 2014-12-31 | ILA995.00K ≈ $2.67K |
ILA-443.00K ≈ $-1.19K |
-0.445x | -815.76% |
| 2013-12-31 | ILA6.91 Million ≈ $18.53K |
ILA-336.00K ≈ $-900.80 |
-0.049x | -173.42% |
| 2009-12-31 | ILA-141.63 Million ≈ $-379.72K |
ILA-9.38 Million ≈ $-25.14K |
0.066x | -26.36% |
| 2008-12-31 | ILA-119.95 Million ≈ $-321.59K |
ILA-10.79 Million ≈ $-28.92K |
0.090x | -- |
About Elbit Med Tech
Elbit Medical Technologies Ltd, an investment holding company, engages in the research, development, production, and marketing of magnetic and focused imaging equipment in the United States, Europe, and internationally. The company is developing a magnetic resonance imaging guided focused ultrasound treatment equipment to address various oncology and gynecology indications, as well as neurologica… Read more